Skip to content

To study the effect of subcutaneous dexmedetomidine for the prevention of shivering in patients undergoing cesarean delivery.

Effect of subcutaneous dexmedetomidine in reducing shivering following cesarean section: a randomized control study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080845
Enrollment
68
Registered
2025-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine group: Will receive subcutaneous dexmedetomidine of dose 0.5 mcg/kg diluted with normal saline to total volume 1 ml just after delivery of the baby and cord clamping Con

Sponsors

All India Institute of Medical Sciences Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologists physical status 2, Scheduled for Cesarean delivery under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Pre-existing structural heart diseases Eclampsia Preeclampsia Cesarean under general anesthesia Psychiatric patient History of convulsions Patients received opioids/ tramadol for shivering management during intraoperative and postoperative periods Patient underwent resurgery

Design outcomes

Primary

MeasureTime frame
Incidence and severity of shivering using patient rated 10 points VAS score after cesarean deliveryTimepoint: At 30 minutes of postoperative period.

Secondary

MeasureTime frame
Incidence and severity using Observer Rated 5 point Likert ScaleTimepoint: At 30 minutes, 4 hours, 8 hours, 12 hours;Post operative pain using NRS scoreTimepoint: At 30 minutes, 4 hours, 8 hours, 12 hours

Countries

India

Contacts

Public ContactAmarjeet Kumar

All India Institute of Medical Sciences Patna

amarjeetdmch@gmail.com9570890646

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026